glp-1 weight loss drug news today october 2025 obesity GLP-1 Drugs: 2025 Pulse Survey (U.S.) GLP-1 Weight-Loss Drug Demonstration Begins
Description
Its December 5, 2017 approval as once weekly Ozempic for diabetes provided potent glycemic control and significant weight loss in a convenient weekly injection
Helmstdter J, Keppeler K, Kster L, Munzel T, Daiber A, Steven S
Novo Nordisks Wegovy pill (oral semaglutide 25 mg, once daily) has just been approved by the US FDA as the first oral GLP1 receptor agonist for longterm weight management and CV risk reduction in people with overweight or obesity
What if I only need to lose a small amount of weight
V., Hertz, C
